Association of a C/T single-nucleotide polymorphism in the 5′ untranslated region of the CD40-gene with Graves' disease in Japanese

被引:48
作者
Ban, Yoshiyuki
Tozaki, Teruaki
Taniyama, Matsuo
Tomita, Motowo
Ban, Yoshio
机构
[1] Showa Univ, Sch Med, Dept Internal Med 3, Shinagawa Ku, Tokyo 1428666, Japan
[2] Showa Univ, Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo 1428666, Japan
[3] Showa Univ, Fujigaoka Hosp, Div Endocrinol & Metab, Yokohama, Kanagawa 227, Japan
关键词
D O I
10.1089/thy.2006.16.443
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
text: Graves' disease (GD) is caused by an interplay of genetic factors and environmental triggers. Recently, a susceptibility locus for GD was mapped to chromosome 20q11 (GD-2). Furthermore, a novel single nucleotide polymorphism (SNP) in the CD40 gene, which is located in 20q11, was found to be associated and linked with GD in Caucasians and in Koreans. Objectives: To examine a C/T SNP in the 5' untranslated region of the CD40 gene (CD40-E1SNP) for association with autoimmune thyroid diseases (AITDs) in a Japanese dataset. Design, setting, and patients: Case-control association studies were performed using the CD40-E1SNP. We studied 485 Japanese patients with AITD (301 with GD, 184 with Hashimoto's thyroiditis [HT]) and 177 matched Japanese control subjects in association studies. Main outcome: Frequencies of genotypes and alleles of the CD40-E1SNP. Results: The distribution of genotype frequencies differed significantly between patients with GD and controls in a dominant manner (p = 0.039). The CC+CT genotypes of the CD40-E1SNP were associated with the increased risk for GD (p = 0.015, odds ratio [OR] = 1.9). In contrast, no differences in genotype frequencies were observed between HT patients and controls for the CD40-E1SNP. Conclusion: These results suggested that the CD40 gene is involved insusceptibility for GD in the Japanese.
引用
收藏
页码:443 / 446
页数:4
相关论文
共 21 条
[1]  
[Anonymous], 1996, HUM MOL GENET
[2]   THE CD40 ANTIGEN AND ITS LIGAND [J].
BANCHEREAU, J ;
BAZAN, F ;
BLANCHARD, D ;
BRIERE, F ;
GALIZZI, JP ;
VANKOOTEN, C ;
LIU, YJ ;
ROUSSET, F ;
SAELAND, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922
[3]   Cigarette smoking and risk of clinically overt thyroid disease - A population-based twin case-control study [J].
Brix, TH ;
Hansen, PS ;
Kyvik, KO ;
Hegedus, L .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (05) :661-666
[4]   Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction [J].
Carayanniotis, G ;
Masters, SR ;
Noelle, RJ .
IMMUNOLOGY, 1997, 90 (03) :421-426
[5]   THE ROLE OF CD40 IN THE REGULATION OF HUMORAL AND CELL-MEDIATED-IMMUNITY [J].
DURIE, FH ;
FOY, TM ;
MASTERS, SR ;
LAMAN, JD ;
NOELLE, RJ .
IMMUNOLOGY TODAY, 1994, 15 (09) :406-411
[6]   Immune regulation by CD40 and its ligand GP39 [J].
Foy, TM ;
Aruffo, A ;
Bajorath, J ;
Buhlmann, JE ;
Noelle, RJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :591-617
[7]   A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians [J].
Heward, JM ;
Simmonds, MJ ;
Carr-Smith, J ;
Foxall, H ;
Franklyn, JA ;
Gough, SCL .
CLINICAL ENDOCRINOLOGY, 2004, 61 (02) :269-272
[8]   Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994):: National Health and Nutrition Examination Survey (NHANES III) [J].
Hollowell, JG ;
Staehling, NW ;
Flanders, WD ;
Hannon, WH ;
Gunter, EW ;
Spencer, CA ;
Braverman, LE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) :489-499
[9]   Role of the CD40 locus in Graves' disease [J].
Houston, FA ;
Wilson, V ;
Jennings, CE ;
Owen, CJ ;
Donaldson, P ;
Perros, P ;
Pearce, SHS .
THYROID, 2004, 14 (07) :506-509
[10]   Epidemiology and estimated population burden of selected autoimmune diseases in the United States [J].
Jacobson, DL ;
Gange, SJ ;
Rose, NR ;
Graham, NMH .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 84 (03) :223-243